Jim Hagood, a seasoned veteran in the biotechnology industry, recently retired from Genomic Health, Inc. after a distinguished 30-year career. As a pivotal leader, Jim spearheaded the development of groundbreaking genomic diagnostics that revolutionized personalized medicine, significantly improving patient outcomes worldwide. His strategic vision and commitment to innovation earned him numerous accolades, cementing his legacy as a pioneer in the field. In retirement, Jim remains an influential figure, dedicating his time to mentoring emerging biotech entrepreneurs and contributing to philanthropic initiatives focused on healthcare advancement.More...
At HLR Bio, biotech research and development, with a particular focus on In Vitro Diagnostics (IVD). Our aim is to support the development of innovative and efficient diagnostic tools that can revolutionize healthcare.
Our partnerships with other biotech companies and research institutions are expanding, allowing us to leverage more resources and expertise. We are also investing in advanced technologies to enhance research capabilities and speed up the development process.
We want to help you solve your current challenges such as regulatory complexities, data analytics, automation, and high R&D costs. To mitigate these, we can help you explore various options with a committment to maintain strict compliance with all relevant regulations.More...